| |
| |
|
| Insider
Information: |
Thompson Craig B. |
| Relationship: |
Director |
| City: |
Kenilworth |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
7,176 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,409,266 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
7,176 |
|
|
| Total
Value |
$1,409,266 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Merck & Co Inc |
MRK |
Director |
2009-11-03 |
5,814 |
2008-05-30 |
0 |
Premium* |
|
|
Charles River Laboratories Inter... |
CRL |
Director |
2023-05-15 |
908 |
2014-01-02 |
0 |
Premium* |
|
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-01-02 |
454 |
2022-10-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
135 |
454 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2023-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
664 |
908 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
40 |
319 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
244 |
244 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
279 |
279 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,657 |
17,586 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2017-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,229 |
14,929 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2016-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,110 |
11,700 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,970 |
8,590 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2014-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,720 |
6,620 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,900 |
3,900 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Director |
– • – |
2009-11-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,462) |
3,352 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Director |
– • – |
2009-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,814 |
5,814 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Director |
– • – |
2009-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,567 |
5,814 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Director |
– • – |
2008-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,567 |
4,247 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Director |
– • – |
2008-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,680 |
1,680 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
